期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CXCL10／CXCR3与乳腺癌关系的研究进展 被引量：2

下载PDF
导出
摘要 乳腺癌是妇女最常见的恶性肿瘤之一，严重危害女性身体健康。由于各种乳腺癌的发展及生物学行为各有特点，因此人们对于乳腺癌的治疗提出了个体化治疗的观点。近年来，寻找特异性的治疗靶点，成为乳腺癌治疗研究中的一个热点。
作者 段波峰（综述） 郑维（审校）
机构地区 南华大学 湖南省人民医院乳甲外科
出处 《医学临床研究》 CAS 2010年第8期1490-1492,共3页 Journal of Clinical Research
关键词 乳腺肿瘤/病理学 受体 趋化因子 综述文献
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Lasagni L, Francalanci M, Annunziato F, et al . An alterna- spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC,and acts as functional receptor for platelet factor 4 [J]. J Exp Med,2003 , 197 (11) : 1537-1549.
  • 2Datta D, Flaxenburg JA, Laxmanan S, et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3- B in MDA-MB-435 and MCF 7 cells: relevance for the development of human breast cancer[J]. Cancer Res , 2006, 66 (19) : 9509-9518.
  • 3Herder C, Hauner H, Kempf K, et al. Constitutive and regulated expression and secretion of interferon gamma inducible protein 10(IP-10 /CXCL10)in human adipocytes[J]. Int J Obes ,2007,31(3) :403-410.
  • 4Luster AD, Leder P. IP-10, a-C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo[J]. J Exp Med ,1993,178(3) :1057-1065.
  • 5Huang H,Xiang J. Synergistic effect of lymphotactin and interferon gamma inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors[J]. Int J Cancer ,2004,109(6) :817-825.
  • 6Lee L K, Roth C M. Antisense technology in molecular and cellular bioengineeing[J]. Curr Opin Biotechnol , 2003, 14 (5) 505-511.
  • 7Dufour JH,Dziejman M,liu MT, et al . IFN-gamma inducible protein 10(IP-10;CXCL10)-deficient mice reveal a role for IP- 10 in effector T cell generation and trafficking [J]. J Immunol, 2002,168(7) :3195-3204.
  • 8Bodnar RJ,Yates CC,Wells A. IP-IO blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of ealpain[J]. Circ Res , 2006,98(5), 617-625.
  • 9Proost P,Schutyser E,Menten P, et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties[J].Blood ,2001,98(13) .3554-3561.
  • 10Kolch W. Regulation of the expression of the VEGF/VPS and its reeeptors. role in tumor angiogenesis[J]. Breast Cancer Res Treat ,1995,36(2) :139-155.

二级参考文献11

  • 1程琳,王杉,叶颖江,张嘉庆,乔新民,杨德启,崔志荣.转染Stat3βcDNA对人乳腺癌细胞的作用[J].中华医学杂志,2005,85(1):23-27. 被引量：2
  • 2Goldberg-Bittman L, Neumark E, Sagi-Assif O, et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett, 2004,92:171-178.
  • 3Guo P, Fang Q, Tao HQ, et al. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo. Cancer Res, 2003,63 : 4684-4691.
  • 4Di GH, Lu JS, Song CG, et al. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas. J Exp Clin Cancer Res, 2005,24:601-607.
  • 5Bodnar R J, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res, 2006,98:617-625.
  • 6Nagpal ML, Chen Y, Lin T. Effects of overexpression of CXCLIO (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation. J Endocrinol, 2004, 183 : 585- 594.
  • 7Huang H, Xiang J. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T- cell localization and adoptive T-cell therapy of tumors. Int J Cancer, 2004,109:817-825.
  • 8Datta D, Flaxenburg JA, Laxmanan S, et al. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res, 2006,66:9509-9515.
  • 9Shen Q, Zhang R, Bhat NR. MAP kinase regulation of IP10/ CXCL10 chemokine gene expression in microglial cells. Brain Res, 2006,1086:9-16.
  • 10Wincewicz A, Sulkowska M, Rutkowski R, et al. STAT1 and STA33 as intracellular regulators of vascular remodeling. Eur J Intern Med, 2007,18:267-271.

共引文献3

同被引文献41

  • 1李长青,尹俊,张燕军,郭志成,张文广,高爱琴,李玉荣,赖双英,李金泉.内蒙古绒山羊与辽宁绒山羊皮肤毛囊周期性变化的比较研究[J].畜牧兽医学报,2005,36(7):674-679. 被引量：50
  • 2Farber JM. A macrophage mRNA selectively induced by gamma- interferon encodes a member of the platelet factor 4 family of cytokines [J]. Proc Natl Acad Sci USA, 1990, 87(14): $238-5242.
  • 3Gasperini S, Marchi M Calzetti F et al. Gene expression and production of the monokine induced by IFN-gamma (MIG),IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN- gamma-inducible protein-10 (IP-10) chemokines by human neutrophils [J]. J Immunol, 1999, 162(8): 4928-4937.
  • 4Rotondi M, Chiovato L, Romagnani S, et al. Role of chemokines in endocrine autoimmune diseases [J]. Endocr Rev, 2007, 28(5): 492-520.
  • 5Rossi D, Zlotnik A. The biology of chemokines and their receptors [J]. Annu Rev Immunol, 2000, 18:217-242.
  • 6Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis [J].J Biol Chem, 1995, 270(45): 27348-27357.
  • 7Romagnani P, Annunziato F, Lasagni L, et al. Cell cycle- dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity [J. J Clin Invest, 2001, 107(1): 53-63.
  • 8Lasagni L, Francalanci M, Annunziato F, et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 [J]. J Exp Med, 2003, 197(11): 1537-1549.
  • 9Datta D, Contreras AG, Grimm M, et al. Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression [J]. J Am Soc Nephrol, 2008, 19(12): 2437-2446.
  • 10Liu L, Callahan MK, Huang D, et al. Chemokine receptor CXCR3: an unexpected enigma [J]. Curr Top Dev Biol, 2005, 68:49-181.

引证文献2

二级引证文献2

医学临床研究
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部